Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

Want to pass the Microsoft AI-102 Azure AI Engineer certification exam on your first try? You are in the right place, because we have put together a collection of sample AI-102 exam questions that ...